Selective PPARγ modulation by amorfrutin B as a novel therapeutic approach to chemotherapy-induced damage to mammalian brain cells

2023/49/N/NZ7/03640

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • NZ3_05: Neurobiologia molekularna
  • NZ3_03: Apoptoza

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Farmakologii PAN

Voivodeship: małopolskie

Other projects carried out by the institution »

Principal investigator (from the host institution)

Bernadeta Angelika Pietrzak-Wawrzyńska

Number of co-investigators in the project: 3

Call

PRELUDIUM 22 – announced on 2023-03-16

Amount awarded
210 000 PLN
Project start date
2024-01-29
Project end date
2027-01-28
Project duration
36 months (the same as in the proposal)
Project status
Pending project

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

« New search

Graphic design and implementation: Jakub Piotrowski